Nutrient mixture including vitamin C, L-lysine, L-proline, and epigallocatechin is ineffective against tumor growth and metastasis in a syngeneic neuroblastoma model

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 284-288

  Lode, Holger N ^a   Huebener, Nicole ^a   Strandsby, Anne ^a   Gaedicke, Gerhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ascorbic acid; Epigallocatechin; L lysine; Neuroblastoma

Indexed keywords

AMINO ACID PLUS ASCORBIC ACID PLUS EPIGALLOCATECHIN GALLATE PLUS LYSINE; ASCORBIC ACID; ASCORBIC ACID PLUS LYSINE; EPICAN FORTE; EPIGALLOCATECHIN GALLATE; LYSINE; PROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; HYPOTHESIS; INOCULATION; LIVER METASTASIS; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCORBIC ACID; CATECHIN; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; LIVER NEOPLASMS, EXPERIMENTAL; LYSINE; MICE; MICE, INBRED A; NEUROBLASTOMA; PROLINE;

EID: 37548999806     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21172     Document Type: Article

References (31)

1. Friedman T, Slayton WB, Allen LS, et al. Use of alternative therapies for children with cancer. Pediatrics 1997; 100:E1.
2. Melnick SJ. Developmental therapeutics: Review of biologically based complementary and alternative medicine (CAM) therapies for potential application in children with cancer-part II. J Pediatr Hematol Oncol 2006;28:271-285.
3. MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002;35:166-173.
4. Fulda S, Friesen C, Los M, et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997;57:4956-4964.
5. Finley JW. Proposed criteria for assessing the efficacy of cancer reduction by plant foods enriched in carotenoids, glucosinolates, polyphenols and selenocompounds. Ann Bot (Lond) 2005;95: 1075-1096.
6. Ivanov V, Roomi MW, Kalinovsky T, et al. Natural nutrient mixture effectively reduces collagen matrix contraction driven by human uterine smooth muscle cells. J Obstet Gynaecol Res 2006;32: 23-31.
7. Roomi MW, Ivanov V, Kalinovsky T, et al. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells. Oncol Rep 2005;14:1399-1404.
8. Roomi MW, Ivanov V, Kalinovsky T, et al. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer 2005;35:97-102.
9. Roomi MW, Ivanov V, Kalinovsky T, et al. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncol Rep 2005;13:253-257.
10. Roomi MW, Ivanov V, Kalinovsky T, et al. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: Evaluation of tumor growth and immunohistochemistry. Oncol Rep 2005;13: 421-425.
11. Roomi MW, Ivanov V, Kalinovsky T, et al. Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24. Int J Urol 2006;13:415-419.
12. Roomi MW, Ivanov V, Kalinovsky T, et al. Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture. Exp Lung Res 2006;32:69-79.
13. Roomi MW, Ivanov V, Kalinovsky T, et al. Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic-acid and green tea extract. J Obstet Gynaecol Res 2006;32:148-154.
14. Roomi MW, Ivanov V, Kalinovsky T, et al. Modulation of human renal cell carcinoma 786-0MMP-2 and MMP-9 activity by inhibitors and inducers in vitro. Med Oncol 2006;23:245-250.
15. Roomi MW, Ivanov V, Kalinovsky T, et al. Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract. Int J Gynecol Cancer 2006;16:1241-1247.
16. Roomi MW, Ivanov V, Kalinovsky T, et al. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7. Med Oncol 2005;22:129-138.
17. Roomi MW, Ivanov V, Kalinovsky T, et al. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080. Med Oncol 2006;23:105-111.
18. Roomi MW, Ivanov V, Netke S, et al. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058. In Vivo 2006;20:25-32.
19. Roomi MW, Roomi NW, Ivanov V, et al. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 2005;7:R291-R295.
20. Wittekind C, Neid M. Cancer invasion and metastasis. Oncology 2005;69:14-16.
21. Lode HN, Xiang R, Varki NM, et al. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J Natl Cancer Inst 1997;89:1586-1594.
22. Lode HN, Moehler T, Xiang R, et al. Synergy between an antiangiogenic integrin av antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases, Proc Nat Acad Sci USA 1999;96:1591-1596.
23. Lode HN, Pertl U, Xiang R, et al. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma. Med Pediatr Oncol 2000;35:641-646.
24. Lode HN, Reisfeld RA, Handgretinger R, et al. Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma. Cancer Res 1998;58: 2925-2928.
25. Lode HN, Xiang R, Dreier T, et al. Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood 1998;91:1706-1715.
26. Lode HN, Xiang R, Duncan SR, et al. Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12. Proc Natl Acad Sci USA 1999; 96:8591-8596.
27. Zeng Y, Fest S, Kunert R, et al. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice. Mol Immunol 2005;42:1311-1319.
28. Lange B, Schroeder U, Huebener N, et al. Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma. Cancer Lett 2003;197:225-230.
29. Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a prodrug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005;102:13604-13609.
30. Padayatty SJ, Riordan HD, Hewitt SM, et al. Intravenously administered vitamin C as cancer therapy: Three cases. CMAJ 2006;174:937-942.
31. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: Implications for oral and intravenous use. Ann Intern Med 2004; 140:533-537.